Patent ID: 11890354
Assignee: CYTOMX THERAPEUTICS, INC.
Field: Pharmaceuticals (Chemistry)
Classification: CPC A  C  G | IPC A  C  G

Claim 3:
4. The method of claim 3, wherein the agent has one or more of the characteristics selected from the group consisting of:
(a) the agent is a toxin or fragment thereof,
(b) the agent is a dolastatin or a derivative thereof,
(c) the agent is an auristatin or derivative thereof,
(d) the agent is auristatin E or a derivative thereof,
(e) the agent is monomethyl auristatin E (MMAE),
(f) the agent is a maytansinoid or a derivative thereof,
(g) the agent is DM1,
(h) the agent is DM4,
(i) the agent is a duocarmycin or derivative thereof,
(j) the agent is a calicheamicin or derivative thereof,
(k) the agent is a detectable moiety, and
(l) the agent is a diagnostic agent.